IL10 and Stroke: The secondary objective of this study was to test the hypothesis that a beneficial role of rPSG1-Fc in experimental stroke is mediated by skewing the immune response to a suppressive phenotype, as assessed by increased FoxP3+ cell counts and IL-10/TGF-β production, and reduced microglial and endothelial activation.